Drug Profile
Hepatitis C vaccine - iQur
Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator iQur
- Class Hepatitis C vaccines
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis C
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Hepatitis-C(Prevention) in United Kingdom (Parenteral)
- 07 Jul 2016 Early research in Hepatitis C (Prevention) in United Kingdom (Parenteral)